Publications
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Bruton's tyrosine kinase inhibitors and their current status in the treatment of chronic lymphocytic leukemia2023 | First Faculty of Medicine
- CAR-T lymfocyty v terapii nehodgkinských lymfomů2023 | First Faculty of Medicine
- The use of immunotherapy and targeted therapy in Richter's transformation2023 | First Faculty of Medicine
Loading network view...